Teva CEO says not too late to launch Humira biosimilar in 20

Teva Pharmaceutical
Industries will still pursue launching a biosimilar of
AbbVie's blockbuster arthritis drug Humira next year
despite a crowded marketplace, Chief Executive Richard Francis
said on...

Related Keywords

New York , United States , Jerusalem , Israel General , Israel , Americans , Patrick Wingrove , Steven Scheer , Caroline Humer , Novarti Sandoz , Richard Francis , Teva Pharmaceutical Industries , Unitedhealth Group Optum , Boehringer Ingelheim , Johnson , Drug Administration , Cigna Group Express Scripts , Reuters , Amgen , Pharmaceutical Industries , Chief Executive Richard Francis , Express Scripts , Unitedhealth Group , Bill Berkrot , Markets ,